We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.33%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$626B
AUM Growth
+$48.2B
Cap. Flow
+$8.1B
Cap. Flow %
1.29%
Top 10 Hldgs %
24.52%
Holding
3,560
New
66
Increased
2,144
Reduced
1,024
Closed
105

Sector Composition

Rank Sector Weight
1 Technology 25.34%
2 Financials 11.49%
3 Consumer Discretionary 9.42%
4 Healthcare 9.25%
5 Industrials 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PETS icon
3451
PetMed Express
PETS
$42.3M
$25.1K ﹤0.01%
10,000
BEAT icon
3452
Heartbeam
BEAT
$32.6M
$24K ﹤0.01%
14,543
BAER icon
3453
Bridger Aerospace
BAER
$76.5M
$23.1K ﹤0.01%
12,500
IMUX icon
3454
Immunic
IMUX
$211M
$22K ﹤0.01%
2,500
MLSS icon
3455
Milestone Scientific
MLSS
$43M
$15.6K ﹤0.01%
34,400
ACET icon
3456
Adicet Bio
ACET
$77M
-1,875
Closed -$18.3K
ACRV icon
3457
Acrivon Therapeutics
ACRV
$74M
-63,636
Closed -$75.7K
AFRI icon
3458
Forafric Global
AFRI
$287M
-11,701
Closed -$91.3K
AGS
3459
DELISTED
PlayAGS
AGS
-24,605
Closed -$307K
ALGS icon
3460
Aligos Therapeutics
ALGS
$45.5M
-25,398
Closed -$183K
ALXO icon
3461
ALX Oncology
ALXO
$267M
-133,433
Closed -$55.4K
AMED
3462
DELISTED
Amedisys
AMED
-349,483
Closed -$34.4M
ANSS
3463
DELISTED
Ansys
ANSS
-596,567
Closed -$210M
APLT
3464
DELISTED
Applied Therapeutics
APLT
-403,514
Closed -$126K
AZEK
3465
DELISTED
The AZEK Co
AZEK
-935,056
Closed -$50.8M
BASE
3466
DELISTED
Couchbase
BASE
-358,645
Closed -$8.74M
BIV icon
3467
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
-90,035
Closed -$6.96M
BLNK icon
3468
Blink Charging
BLNK
$85.5M
-542,875
Closed -$510K
BLV icon
3469
Vanguard Long-Term Bond ETF
BLV
$5.7B
-347,170
Closed -$24.1M
BMEA icon
3470
Biomea Fusion
BMEA
$93.5M
-116,549
Closed -$210K
BPMC
3471
DELISTED
Blueprint Medicines
BPMC
-561,159
Closed -$71.9M
BRDG
3472
DELISTED
Bridge Investment Group
BRDG
-13,968
Closed -$140K
BRKL
3473
DELISTED
Brookline Bancorp
BRKL
-1,021,803
Closed -$10.8M
BSCP
3474
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
-171,498
Closed -$3.55M
CDLX icon
3475
Cardlytics
CDLX
$22.4M
-26,972
Closed -$444K

Similar funds

Charles Schwab's Q3 2025 Portfolio in Review

As of Q3 2025, Charles Schwab held 3,560 positions worth $626B, up 8.3% from $578B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 4.8%. Charles Schwab opened 66 new positions and exited 105, leaving the 3,560-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Charles Schwab's largest Q3 2025 buy was BitMine Immersion Technologies: 1,712,780 shares worth $88.9M.
  • Charles Schwab added most to Schwab Core Bond ETF in Q3 2025, an estimated $623M increase.
  • Charles Schwab's biggest Q3 2025 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $542M.
  • Charles Schwab fully exited Hess in Q3 2025, selling an estimated $275M.
  • Charles Schwab's ten largest holdings make up 25% of its $626B portfolio in Q3 2025.
  • Charles Schwab opened 66 new positions and closed 105 in Q3 2025.
  • Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $626B.

Based on Charles Schwab's 13F filing for Q3 2025, filed 10 Nov 2025.